Indosolar Limited — Annual Report FY2026
Quality Scores
AI Summary
Indosolar Limited is currently a business in a state of high-risk structural transition under new ownership (Waaree Group). Historically, the company was a failed solar cell manufacturer that entered the Corporate Insolvency Resolution Process (CIRP) after shutting its Greater Noida facility in 2018. Following the acquisition by Waaree, the company is attempting to pivot from legacy cell production to setting up modern solar module manufacturing lines. While FY26 figures show a sudden spike in revenue (₹679.85 Cr) and PAT (₹246.60 Cr), this follows years of zero operations and massive capital…
Key Changes
Indosolar's journey is a stark narrative of obsolescence followed by a potential renaissance. From 2014 to 2018, the company struggled with legacy cell manufacturing technology, eventually shutting down all operations in May 2018. It remained a 'zombie' company for several years while undergoing insolvency proceedings. The pivot occurred post-2022 when Waaree Energies took over, shifting the strategic focus from defunct cell lines to modern module manufacturing. The FY26 results show a massive jump in revenue to ₹679.85 Cr, signaling that the company has finally moved from stagnation to active production. This represents an 'Exceptional Transformation' from a bankrupt entity to an operational arm of India's largest solar player.
Management Commentary
The management quality has undergone a 180-degree shift following the NCLT-led acquisition by the Waaree Group. The legacy management was unable to navigate the competitive pressures of the solar industry, leading to a total operational collapse. The new leadership, led by appointments like Abhishek Pareek (CFO), is focused on institutionalizing operations and integrating with Waaree's ecosystem. Transparency has improved significantly with regular FY26 audited result filings and management updates. However, the short track record of the current team at this specific entity makes long-term management quality assessment difficult.
Financial Highlights
The 10-year financial trajectory is characterized by long periods of zero sales and heavy losses until the Waaree acquisition. Revenue growth in FY26 appears as a'jump-start' rather than organic compounding, reflecting the commissioning of new capacities under the resolution plan. Net margins in the most recent periods are exceptionally high (approx 36%), which may be unsustainable and potentially influenced by accounting adjustments common in post-insolvency turnarounds. Historically, equity was almost entirely wiped out, and the current balance sheet is a result of debt restructuring. Capital efficiency metrics like ROE and ROCE are currently volatile and do not yet reflect a stabilized industrial steady-state.
Major Opportunities
- Acquisition by Waaree Group (industry leader)
- Sharp revenue turnaround in FY25/FY26
- Successful exit from IBC/Insolvency phase
Major Risks
- Manufacturing plant was closed for nearly 6 years
- History of massive capital erosion
- Legacy cells business was uncompetitive vs imports
Unlock the full report
Unlock complete company intelligence with 20+ analysis sections, visual insights, AI chat, rankings, and downloadable PDF reports.